Clinical Trial Update: Does Nightly Dexmedetomidine Improve Sleep and Reduce Delirium in ICU Patients? [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated whether nightly dexmedetomidine improves sleep and reduces delirium in ICU patients; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Maisonneuve-Rosemont Hospital | Conditions: Sleep Deprivation, Delirium | Phase 4 | Status: COMPLETED